Statistics

Total Visits

Views
A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study.109

Select a period of time:

Number of views in the range

Views
A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study.42

Views

Views
December 20257
January 20264
February 20263
March 20263
April 20260
May 20267
June 202618
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States16
Netherlands4
Canada2
Chile2
Finland2
United Kingdom2
Morocco2
Mexico2
Brazil2
Argentina1
 

Top cities views

Views
Groningen4
Santiago2
Helsinki2
Belle Mead1
Bremen1
Cape Town1
Culiacán1
Curepipe1
Duque de Caxias1
El Jadida1